Based

Two gene variants may predict who will benefit from breast cancer prevention drugs

SALUTE DOMANI ∞ IL PORTALE DEL BENESSERE ieri alle 7:45

In women at high risk for breast cancer, a long-term drug treatment can cut the risk of developing the disease in half...
FDA approves dabrafenib (TAFINLAR capsule) for unresectable or metastatic melanoma

SALUTE DOMANI ∞ IL PORTALE DEL BENESSERE 31 maggio

The U. S. Food and Drug Administration (FDA) approved dabrafenib (TAFINLAR capsule, GlaxoSmithKline, LLC), for the treatment of patients with unresectable or metastatic...
Skin cancer: FDA approves Mekinist (trametinib) for unresecable or metastatic melanoma with BRAF V600E or V600K mutation

SALUTE DOMANI ∞ IL PORTALE DEL BENESSERE 31 maggio

The U. S. Food and Drug Administration approved trametinib (MEKINIST tablet, GlaxoSmithKline, LLC), for the treatment of patients with unresectable or metastatic...
RELAX-AHF shows first positive findings in HFpEF patients, VIVIDD reveals vildagliptin non-inferior to placebo

SALUTE DOMANI ∞ IL PORTALE DEL BENESSERE 26 maggio

Serelaxin may be more effective for relieving dyspnea in heart failure with preserved ejection fraction (HFpEF) than reduced (HFrEF) during the first 24 hours,...
Austeri ed abiure

Phastidio.net 21 maggio

Sul suo blog, l’economista statunitense Jeff Frankel si occupa delle ultime polemiche che hanno coinvolto alcune “grandi firme” di Harvard, e giunge alla...

Argomenti di oggi